Rhythm Pharmaceuticals (RYTM) PT Raised to $120 at Guggenheim
Tweet
Share
E-mailGet Alerts RYTM Hot Sheet
Price: $115.98 -0.03%
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Guggenheim analyst Seamus Fernandez raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $120.00 (from $119.00) while maintaining a Buy rating.
You May Also Be Interested In
- UK regulator expands Imcivree approval to hypothalamic obesity
- Diversified Royalty Corp (DIV:CN) (BEVFF) PT Lowered to Cdn$4.75 at Desjardins
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
